Identity
- Security key
- 19497
- Ticker
- OABI
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2022-11-01
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- OABI
Detail
Enriched 2026-08-14 20:47
- Market cap
- $497,235,161.16
- Shares outstanding (class)
- 144,972,579
- Shares outstanding (weighted)
- 145,390,398
- SIC
- 8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Employees
- 89
- Location
- EMERYVILLE, CA
- Homepage
- https://www.omniab.com
- Description
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Market cap and share counts drift.